scholarly article | Q13442814 |
P50 | author | Nuria DeGregorio-Rocasolano | Q73076722 |
P2093 | author name string | Octavi Martí-Sistac | |
Teresa Gasull | |||
P2860 | cites work | Iron overload prevents oxidative damage to rat brain after chlorpromazine administration | Q88687824 |
Low-molecular-mass iron in healthy blood plasma is not predominately ferric citrate | Q88888632 | ||
Endothelial cells are critical regulators of iron transport in a model of the human blood-brain barrier | Q89133438 | ||
Different Characteristics of Hepcidin Expression in IL-6+/+ and IL-6-/- Neurons and Astrocytes Treated with Lipopolysaccharides | Q89161275 | ||
Iron Overload Exacerbates the Risk of Hemorrhagic Transformation After tPA (Tissue-Type Plasminogen Activator) Administration in Thromboembolic Stroke Mice | Q90293026 | ||
Hemopexin reduces blood-brain barrier injury and protects synaptic plasticity in cerebral ischemic rats by promoting EPCs through the HO-1 pathway | Q90854055 | ||
Glutathione peroxidase 4 participates in secondary brain injury through mediating ferroptosis in a rat model of intracerebral hemorrhage | Q91386173 | ||
sAPP modulates iron efflux from brain microvascular endothelial cells by stabilizing the ferrous iron exporter ferroportin | Q24298395 | ||
Iron-export ferroxidase activity of β-amyloid precursor protein is inhibited by zinc in Alzheimer's disease | Q24298553 | ||
Severe iron deficiency anemia in transgenic mice expressing liver hepcidin | Q24536163 | ||
Distinct mechanisms of ferritin delivery to lysosomes in iron-depleted and iron-replete cells | Q24634199 | ||
Natural history of the bruise: formation, elimination, and biological effects of oxidized hemoglobin | Q26862163 | ||
Transferrin-mediated cellular iron delivery | Q27004133 | ||
Divalent metal transporter 1 (DMT1) in the brain: implications for a role in iron transport at the blood-brain barrier, and neuronal and glial pathology | Q27021146 | ||
Transferrin Receptor 2 Dependent Alterations of Brain Iron Metabolism Affect Anxiety Circuits in the Mouse | Q27321138 | ||
Disrupting GluA2-GAPDH Interaction Affects Axon and Dendrite Development | Q27322805 | ||
Comparison of the interactions of transferrin receptor and transferrin receptor 2 with transferrin and the hereditary hemochromatosis protein HFE | Q28140888 | ||
Characterization of glyceraldehyde-3-phosphate dehydrogenase as a novel transferrin receptor | Q28252495 | ||
Deletion of the hemopexin or heme oxygenase-2 gene aggravates brain injury following stroma-free hemoglobin-induced intracerebral hemorrhage | Q28272786 | ||
The macrophage cell surface glyceraldehyde-3-phosphate dehydrogenase is a novel transferrin receptor | Q28275180 | ||
Iron behaving badly: inappropriate iron chelation as a major contributor to the aetiology of vascular and other progressive inflammatory and degenerative diseases | Q28388335 | ||
Inactivation of the ferroptosis regulator Gpx4 triggers acute renal failure in mice | Q28396141 | ||
Age-Dependent Retinal Iron Accumulation and Degeneration in Hepcidin Knockout Mice | Q28506439 | ||
Efficacy of deferoxamine in animal models of intracerebral hemorrhage: a systematic review and stratified meta-analysis | Q28547438 | ||
Lack of hepcidin gene expression and severe tissue iron overload in upstream stimulatory factor 2 (USF2) knockout mice | Q28586797 | ||
Inhibition of the iron-catalysed formation of hydroxyl radicals from superoxide and of lipid peroxidation by desferrioxamine | Q40284629 | ||
Neuronal Death After Hemorrhagic Stroke In Vitro and In Vivo Shares Features of Ferroptosis and Necroptosis | Q40312201 | ||
Increased brain hemopexin levels improve outcomes after intracerebral hemorrhage. | Q40467309 | ||
Mitochondrial Ferritin Protects Hydrogen Peroxide-Induced Neuronal Cell Damage | Q41108761 | ||
Endosome-mitochondria interactions are modulated by iron release from transferrin. | Q41189468 | ||
Transport of iron in the blood-brain-cerebrospinal fluid system. | Q41540088 | ||
Iron-related brain damage in patients with intracerebral hemorrhage | Q48292711 | ||
Iron overload, measured as serum ferritin, increases brain damage induced by focal ischemia and early reperfusion. | Q48349812 | ||
Increased body iron stores are associated with poor outcome after thrombolytic treatment in acute stroke. | Q48351055 | ||
Movement Disorders Associated With Hemochromatosis | Q48435646 | ||
Endothelin-1-mediated vasoconstriction alters cerebral gene expression in iron homeostasis and eicosanoid metabolism | Q48536108 | ||
Tau deficiency induces parkinsonism with dementia by impairing APP-mediated iron export. | Q48686425 | ||
Role of hepcidin and its downstream proteins in early brain injury after experimental subarachnoid hemorrhage in rats | Q48702179 | ||
Cystine/glutamate antiporter blockage induces myelin degeneration. | Q48703799 | ||
Early-stage investigations of ultrasmall superparamagnetic iron oxide-induced signal change after permanent middle cerebral artery occlusion in mice | Q48704896 | ||
Hypoxic preconditioning increases iron transport rate in astrocytes. | Q48749745 | ||
Angiotensin II inhibits uptake of transferrin-bound iron but not non-transferrin-bound iron by cultured astrocytes | Q48802700 | ||
Cytoprotective role of haptoglobin in brain after experimental intracerebral hemorrhage | Q49095078 | ||
Semaphorin4A and H-ferritin utilize Tim-1 on human oligodendrocytes: A novel neuro-immune axis. | Q49852265 | ||
Hepcidin, an emerging and important player in brain iron homeostasis | Q49885816 | ||
Ferroptosis is associated with oxygen-glucose deprivation/reoxygenation-induced Sertoli cell death | Q50047949 | ||
Neurotransmitters in the mediation of cerebral ischemic injury | Q50084655 | ||
13 reasons why the brain is susceptible to oxidative stress | Q50136704 | ||
Iron released from reactive microglia by noggin improves myelin repair in the ischemic brain | Q50178537 | ||
Impaired Transferrin Receptor Palmitoylation and Recycling in Neurodegeneration with Brain Iron Accumulation | Q50209845 | ||
Biomarkers of Functional Outcome in Intracerebral Hemorrhage: Interplay between Clinical Metrics, CD163, and Ferritin | Q50211226 | ||
Identification of the receptor scavenging hemopexin-heme complexes | Q50337480 | ||
Hepcidin Suppresses Brain Iron Accumulation by Downregulating Iron Transport Proteins in Iron-Overloaded Rats. | Q42200495 | ||
Transport of Non-Transferrin Bound Iron to the Brain: Implications for Alzheimer's Disease | Q42261227 | ||
Ablation of ferroptosis regulator glutathione peroxidase 4 in forebrain neurons promotes cognitive impairment and neurodegeneration | Q42321081 | ||
Iron and iron-handling proteins in the brain after intracerebral hemorrhage. | Q42452709 | ||
Extrasynaptic glutamate release through cystine/glutamate antiporter contributes to ischemic damage | Q42592261 | ||
NMDA receptor-nitric oxide transmission mediates neuronal iron homeostasis via the GTPase Dexras1. | Q42855743 | ||
Baicalein is neuroprotective in rat MCAO model: role of 12/15-lipoxygenase, mitogen-activated protein kinase and cytosolic phospholipase A2. | Q42967962 | ||
Haptoglobin increases the vulnerability of CD163-expressing neurons to hemoglobin | Q43117650 | ||
Increased hippocampal expression of the divalent metal transporter 1 (DMT1) mRNA variants 1B and +IRE and DMT1 protein after NMDA-receptor stimulation or spatial memory training. | Q43298541 | ||
Iron overload is associated with perihematoma edema growth following intracerebral hemorrhage that may contribute to in-hospital mortality and long-term functional outcome | Q43720568 | ||
Distribution of divalent metal transporter 1 and metal transport protein 1 in the normal and Belgrade rat. | Q43825415 | ||
Iron intake increases infarct volume after permanent middle cerebral artery occlusion in rats | Q44167726 | ||
Iron handling in hippocampal neurons: activity-dependent iron entry and mitochondria-mediated neurotoxicity. | Q44293701 | ||
Neuroprotection by tempol in a model of iron-induced oxidative stress in acute ischemic stroke | Q44639119 | ||
Deferoxamine-induced attenuation of brain edema and neurological deficits in a rat model of intracerebral hemorrhage | Q44834390 | ||
Administration of N-acetylcysteine after focal cerebral ischemia protects brain and reduces inflammation in a rat model of experimental stroke | Q44870573 | ||
Does nitric oxide contribute to iron-dependent brain injury after experimental cerebral ischaemia? | Q44911908 | ||
Near-infrared fluorescence imaging with fluorescently labeled albumin: a novel method for non-invasive optical imaging of blood-brain barrier impairment after focal cerebral ischemia in mice. | Q46019250 | ||
Iron is a potential key mediator of glutamate excitotoxicity in spinal cord motor neurons. | Q46168553 | ||
Neuronal glutathione deficiency and age-dependent neurodegeneration in the EAAC1 deficient mouse. | Q46179370 | ||
Iron-loaded transferrin (Tf) is detrimental whereas iron-free Tf confers protection against brain ischemia by modifying blood Tf saturation and subsequent neuronal damage | Q46238150 | ||
Iron-induced generation of mitochondrial ROS depends on AMPK activity | Q46352031 | ||
Mitochondrial ferritin suppresses MPTP-induced cell damage by regulating iron metabolism and attenuating oxidative stress | Q46573268 | ||
Temporal changes in free iron levels after brain ischemia Relevance to the timing of iron chelation therapy in stroke. | Q46591323 | ||
Systemic administration of Zn2+ during the reperfusion phase of transient cerebral ischaemia protects rat hippocampus against iron-catalysed postischaemic injury | Q46607907 | ||
Hypoxia-Induced Iron Accumulation in Oligodendrocytes Mediates Apoptosis by Eliciting Endoplasmic Reticulum Stress. | Q46677308 | ||
Apoptotic cell death progression after photothrombotic focal cerebral ischaemia: effects of the lipophilic iron chelator 2,2'-dipyridyl. | Q46714617 | ||
H-ferritin is the major source of iron for oligodendrocytes | Q46812824 | ||
Iron levels in the human brain: a post-mortem study of anatomical region differences and age-related changes | Q46990247 | ||
CHOP induces apoptosis by affecting brain iron metabolism in rats with subarachnoid hemorrhage | Q47240717 | ||
Why should neuroscientists worry about iron? The emerging role of ferroptosis in the pathophysiology of neuroprogressive diseases. | Q47242531 | ||
Dietary lipophilic iron accelerates regional brain iron-load in C57BL6 mice. | Q47371821 | ||
Ferritin is secreted via two distinct non-classical vesicular pathways. | Q47406586 | ||
Regulation of iron metabolism by hypoxia-inducible factors | Q47612424 | ||
Regulatory mechanisms for iron transport across the blood-brain barrier | Q47622852 | ||
Tau-mediated iron export prevents ferroptotic damage after ischemic stroke | Q47626563 | ||
The impact of obesity on brain iron levels and α-synuclein expression is regionally dependent | Q47649474 | ||
Inhibiting 12/15-lipoxygenase to treat acute stroke in permanent and tPA induced thrombolysis models | Q47699668 | ||
Neuroprotective effect of deferoxamine on N-methyl-d-aspartate-induced excitotoxicity in RGC-5 cells | Q47773091 | ||
Specific rescue by ortho-hydroxy atorvastatin of cortical GABAergic neurons from previous oxygen/glucose deprivation: role of pCREB. | Q47780560 | ||
The effect of ethyl pyruvate and N-acetylcysteine on ischemia-reperfusion injury in an experimental model of ischemic stroke | Q47818081 | ||
The cystine-glutamate exchanger (xCT, Slc7a11) is expressed in significant concentrations in a subpopulation of astrocytes in the mouse brain | Q47852091 | ||
Hypoxia induced downregulation of hepcidin is mediated by platelet derived growth factor BB. | Q47903353 | ||
Serum hepcidin concentrations correlate with serum iron level and outcome in patients with intracerebral hemorrhage | Q48154236 | ||
Brain transcriptome perturbations in the transferrin receptor 2 mutant mouse support the case for brain changes in iron loading disorders, including effects relating to long-term depression and long-term potentiation. | Q48202596 | ||
Hepcidin Levels Are Increased in Patients with Acute Ischemic Stroke: Preliminary Report. | Q48226474 | ||
CD163 Expression in Neurons After Experimental Intracerebral Hemorrhage | Q48237746 | ||
Induction of ferroptosis and mitochondrial dysfunction by oxidative stress in PC12 cells | Q48251501 | ||
Astrocyte heme oxygenase-1 reduces mortality and improves outcome after collagenase-induced intracerebral hemorrhage. | Q48254187 | ||
Deletion of aldose reductase leads to protection against cerebral ischemic injury | Q48275982 | ||
Scara5 is a ferritin receptor mediating non-transferrin iron delivery | Q28587430 | ||
The gene encoding the iron regulatory peptide hepcidin is regulated by anemia, hypoxia, and inflammation | Q29620394 | ||
Ablation of the Ferroptosis Inhibitor Glutathione Peroxidase 4 in Neurons Results in Rapid Motor Neuron Degeneration and Paralysis | Q30680014 | ||
The role of iron in brain ageing and neurodegenerative disorders. | Q30852753 | ||
Cytoprotective efficacy and mechanisms of the liposoluble iron chelator 2,2'-dipyridyl in the rat photothrombotic ischemic stroke model. | Q33205268 | ||
Potential Pathways for CNS Drug Delivery Across the Blood-Cerebrospinal Fluid Barrier | Q33646512 | ||
Hepcidin Protects Neuron from Hemin-Mediated Injury by Reducing Iron. | Q33715625 | ||
Binding and uptake of H-ferritin are mediated by human transferrin receptor-1. | Q33734849 | ||
Heme-induced neutrophil extracellular traps contribute to the pathogenesis of sickle cell disease | Q33749670 | ||
Sac-1004, a vascular leakage blocker, reduces cerebral ischemia-reperfusion injury by suppressing blood-brain barrier disruption and inflammation | Q33827436 | ||
Transient expression of transferrin receptors and localisation of iron in amoeboid microglia in postnatal rats | Q33880859 | ||
Special delivery: distributing iron in the cytosol of mammalian cells | Q33931756 | ||
Ferroptosis: an iron-dependent form of nonapoptotic cell death | Q34032093 | ||
Hepcidin is involved in iron regulation in the ischemic brain | Q34034801 | ||
Glutaminolysis and Transferrin Regulate Ferroptosis | Q34044434 | ||
Ischemic cerebral damage: an appraisal of synaptic failure | Q34114236 | ||
Cysteine transport through excitatory amino acid transporter 3 (EAAT3). | Q34282413 | ||
Synchronized renal tubular cell death involves ferroptosis. | Q34447203 | ||
Oxidative Stress in Ischemic Brain Damage: Mechanisms of Cell Death and Potential Molecular Targets for Neuroprotection | Q34700207 | ||
Increased striatal injury and behavioral deficits after intracerebral hemorrhage in hemopexin knockout mice | Q34700468 | ||
Iron mediates N-methyl-D-aspartate receptor-dependent stimulation of calcium-induced pathways and hippocampal synaptic plasticity | Q34787203 | ||
Glutathione peroxidase 4 senses and translates oxidative stress into 12/15-lipoxygenase dependent- and AIF-mediated cell death | Q34818662 | ||
A novel model for brain iron uptake: introducing the concept of regulation | Q34957468 | ||
Glial cell ceruloplasmin and hepcidin differentially regulate iron efflux from brain microvascular endothelial cells | Q35095623 | ||
Molecular mechanisms of non-transferrin-bound and transferring-bound iron uptake in primary hippocampal neurons | Q35528429 | ||
Brain structure in healthy adults is related to serum transferrin and the H63D polymorphism in the HFE gene | Q35887105 | ||
Ferritinophagy via NCOA4 is required for erythropoiesis and is regulated by iron dependent HERC2-mediated proteolysis. | Q36119759 | ||
The intrathecal CD163-haptoglobin-hemoglobin scavenging system in subarachnoid hemorrhage | Q36141369 | ||
Effects of deferoxamine on blood-brain barrier disruption after subarachnoid hemorrhage | Q36294154 | ||
Ischemic preconditioning attenuates brain edema after experimental intracerebral hemorrhage | Q36399779 | ||
A combination of serum iron, ferritin and transferrin predicts outcome in patients with intracerebral hemorrhage. | Q36602560 | ||
Inflammation after intracerebral hemorrhage | Q36620460 | ||
Brain iron toxicity: differential responses of astrocytes, neurons, and endothelial cells | Q36778839 | ||
Iron, oxidative stress and early neurological deterioration in ischemic stroke | Q36789577 | ||
Blood-derived iron mediates free radical production and neuronal death in the hippocampal CA1 area following transient forebrain ischemia in rat. | Q50440103 | ||
Expression of divalent metal transporter 1 in primary hippocampal neurons: reconsidering its role in non-transferrin-bound iron influx. | Q50507011 | ||
Cytosolic iron chaperones: Proteins delivering iron cofactors in the cytosol of mammalian cells. | Q50944156 | ||
Successful Treatment of Iron-Overload Cardiomyopathy in Hereditary Hemochromatosis With Deferoxamine and Deferiprone. | Q51359025 | ||
Erythroid cell mitochondria receive endosomal iron by a "kiss-and-run" mechanism. | Q51508013 | ||
Iron-related damage in acute ischemic stroke. | Q51594291 | ||
Iron-chelating agents attenuate NMDA-Induced neuronal injury via reduction of oxidative stress in the rat retina. | Q51741125 | ||
The Aging of Iron Man. | Q51758684 | ||
Unraveling the Burden of Iron in Neurodegeneration: Intersections with Amyloid Beta Peptide Pathology. | Q51759208 | ||
In vivo optical imaging of ischemic blood-brain barrier disruption. | Q52615604 | ||
Iron transport kinetics through blood-brain barrier endothelial cells. | Q52688626 | ||
Deferoxamine therapy for intracerebral hemorrhage: A systematic review. | Q53276190 | ||
Oxytosis/Ferroptosis-(Re-) Emerging Roles for Oxidative Stress-Dependent Non-apoptotic Cell Death in Diseases of the Central Nervous System. | Q54946045 | ||
Distribution of divalent metal transporter 1 and metal transport protein 1 in the normal and Belgrade rat | Q54975411 | ||
Heme and hemoglobin suppress amyloid β-mediated inflammatory activation of mouse astrocytes. | Q54976953 | ||
Hemoglobin metabolism by-products are associated with an inflammatory response in patients with hemorrhagic stroke. | Q55053873 | ||
Unsolved mysteries: How does lipid peroxidation cause ferroptosis? | Q55447080 | ||
Transferrin and transferrin receptors update | Q56362612 | ||
N-acetylcysteine targets 5 lipoxygenase-derived, toxic lipids and can synergize with PGE to inhibit ferroptosis and improve outcomes following hemorrhagic stroke in mice | Q57182391 | ||
Glyceraldehyde-3-phosphate dehydrogenase is a chaperone that allocates labile heme in cells | Q57255599 | ||
Marked Age-Related Changes in Brain Iron Homeostasis in Amyloid Protein Precursor Knockout Mice | Q58418256 | ||
Non-transferrin-bound iron is present in serum of hereditary haemochromatosis heterozygotes | Q73486382 | ||
Serum hepcidin levels are innately low in HFE-related haemochromatosis but differ between C282Y-homozygotes with elevated and normal ferritin levels | Q81464814 | ||
Serum ferritin in stroke: a marker of increased body iron stores or stroke severity? | Q81760530 | ||
Hemopexin increases the neurotoxicity of hemoglobin when haptoglobin is absent | Q87945527 | ||
Hepcidin regulation in a mouse model of acute hypoxia | Q88066758 | ||
Inflammation-induced iron transport and metabolism by brain microglia | Q88248784 | ||
Dexras1, a small GTPase, is required for glutamate-NMDA neurotoxicity | Q37013755 | ||
Heme oxygenase-1-mediated neuroprotection in subarachnoid hemorrhage via intracerebroventricular deferoxamine | Q37251286 | ||
Deferoxamine reduces neuronal death and hematoma lysis after intracerebral hemorrhage in aged rats. | Q37262595 | ||
Optical imaging to map blood-brain barrier leakage | Q37272503 | ||
Intranasal deferoxamine provides increased brain exposure and significant protection in rat ischemic stroke | Q37312849 | ||
Effects of deferoxamine on brain injury after transient focal cerebral ischemia in rats with hyperglycemia. | Q37332307 | ||
Brain iron accumulation affects myelin-related molecular systems implicated in a rare neurogenetic disease family with neuropsychiatric features | Q37364099 | ||
Hemin uptake and release by neurons and glia | Q37477565 | ||
Brain capillary endothelium and choroid plexus epithelium regulate transport of transferrin-bound and free iron into the rat brain. | Q37693717 | ||
HFE gene variants affect iron in the brain | Q37846398 | ||
The oxidative stress-inducible cystine/glutamate antiporter, system x (c) (-) : cystine supplier and beyond | Q37853443 | ||
Functional roles of transferrin in the brain | Q37964393 | ||
The role of hepatic transferrin receptor 2 in the regulation of iron homeostasis in the body | Q38196802 | ||
Heme on innate immunity and inflammation | Q38218093 | ||
Molecular regulation of cellular iron balance. | Q38557699 | ||
Cerebral ischemia/repefusion injury: From bench space to bedside | Q38669673 | ||
Ferroptosis: Role of lipid peroxidation, iron and ferritinophagy | Q38677938 | ||
Molecular, Cellular and Clinical Aspects of Intracerebral Hemorrhage: Are the Enemies Within? | Q38682340 | ||
Mitochondrial ferritin protects SH-SY5Y cells against H2O2-induced oxidative stress and modulates α-synuclein expression | Q38717872 | ||
Inhibition of neuronal ferroptosis protects hemorrhagic brain | Q38730939 | ||
Reverse overshot water-wheel retroendocytosis of apotransferrin extrudes cellular iron | Q38805784 | ||
Neuroprotection in acute stroke: targeting excitotoxicity, oxidative and nitrosative stress, and inflammation | Q38834682 | ||
Is There a Link Between Changes in Levels of Hepcidin and Stroke? | Q38907447 | ||
Iron importers Zip8 and Zip14 are expressed in retina and regulated by retinal iron levels. | Q39037572 | ||
Regulation of the Iron Homeostatic Hormone Hepcidin | Q39092558 | ||
Ferritin, cellular iron storage and regulation | Q39204430 | ||
Overexpression of human wild-type amyloid-β protein precursor decreases the iron content and increases the oxidative stress of neuroblastoma SH-SY5Y cells | Q39373390 | ||
Toll-Like Receptor 4/MyD88-Mediated Signaling of Hepcidin Expression Causing Brain Iron Accumulation, Oxidative Injury, and Cognitive Impairment After Intracerebral Hemorrhage. | Q39439180 | ||
Nutritional hepatic iron overload is not prevented by parenteral hepcidin substitution therapy in mice | Q39654245 | ||
Heme controls ferroportin1 (FPN1) transcription involving Bach1, Nrf2 and a MARE/ARE sequence motif at position -7007 of the FPN1 promoter | Q39736112 | ||
Lysosomal iron modulates NMDA receptor-mediated excitation via small GTPase, Dexras1. | Q39849726 | ||
Tim-2 is the receptor for H-ferritin on oligodendrocytes | Q39915760 | ||
Dexras1 a unique ras-GTPase interacts with NMDA receptor activity and provides a novel dissociation between anxiety, working memory and sensory gating | Q39945428 | ||
Association between serum ferritin level and perihematoma edema volume in patients with spontaneous intracerebral hemorrhage | Q40121434 | ||
Terephthalamide-containing ligands: fast removal of iron from transferrin | Q40155984 | ||
Iron in Frontotemporal Lobar Degeneration: A New Subcortical Pathological Pathway? | Q40268144 | ||
P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
P6216 | copyright status | copyrighted | Q50423863 |
P407 | language of work or name | English | Q1860 |
P921 | main subject | excitotoxicity | Q901117 |
Transferrin saturation | Q907072 | ||
neurodegeneration | Q1755122 | ||
P304 | page(s) | 85 | |
P577 | publication date | 2019-02-19 | |
P1433 | published in | Frontiers in Neuroscience | Q2177807 |
P1476 | title | Deciphering the Iron Side of Stroke: Neurodegeneration at the Crossroads Between Iron Dyshomeostasis, Excitotoxicity, and Ferroptosis | |
P478 | volume | 13 |
Q91864307 | Achyranthes bidentata polypeptides prevent apoptosis by inhibiting the glutamate current in cultured hippocampal neurons |
Q100332922 | Crosstalk Between Autophagy and Ferroptosis and Its Putative Role in Ischemic Stroke |
Q94560640 | Nrf2 and Ferroptosis: A New Research Direction for Neurodegenerative Diseases |
Q93043640 | Population Dynamics in Cell Death: Mechanisms of Propagation |
Q92856504 | The Emerging Roles of Ferroptosis in Vascular Cognitive Impairment |
Q97066904 | The Potential Value of Targeting Ferroptosis in Early Brain Injury After Acute CNS Disease |
Q90283779 | What Is Next in This "Age" of Heme-Driven Pathology and Protection by Hemopexin? An Update and Links with Iron |
Search more.